Sylogent Launches Structured Data and Information Management Platform for Pharmaceutical Industry

NEWTOWN, Pa., Aug. 2, 2016 /PRNewswire/ -- Sylogent, a software and data services company, has announced the formal launch of SYQUENCE for the pharmaceutical industry.  The web-based system is designed to organize, standardize and automate the data necessary to produce critical information.

SYQUENCE is a flexible middleware tool that allows for structured data-driven processes to be implemented with minimal business interruptions. Integrated structured templates automatically create structured documents that maximize data consistency within a department and across the organization.  

"With more regulations, fewer resources, smaller budgets and shorter compliance timelines, the industry must begin to automate their information processes," stated Jack Yeager, CEO of Sylogent. "They cannot continue to manually process this heavily regulated information that ultimately must be consistent across the organization and public domain."

SYQUENCE has been deployed at several pharmaceutical companies to assist with study registration, clinical data disclosure and publication planning. The single Study Master Form automatically creates all of the required registration and data disclosure documents populated with shared data elements. The system also creates a publication study document that includes study data needed by publication teams.

"Too much critical data is being managed in spreadsheets, word documents and within emails on laptops and desktops. Pharma must operate in real time if they expect to satisfy growing compliance regulations," said Yeager.

To learn about SYQUENCE, visit syquence.com or email [email protected]

About Sylogent

Sylogent develops software that maximizes regulatory compliance, reduces operational costs and optimizes resource value. We leverage an integrated knowledge of process, data, technology and people to design solutions that deliver measurable results.

To learn about Sylogent, visit sylogent.com or email [email protected]

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com

SOURCE Sylogent